Thomas Berryman has extensive experience in bringing venture funded medical technology companies from initial startup through product commercialization, revenue growth and exit. Prior to founding Soft Health Technologies, he served as President and CEO of WaveTec Vision Systems (now part of Alcon) from its initial venture funding in 2005, taking it from benchtop prototype through clinical validation and early commercialization, until September 2010. Prior to joining WaveTec, Tom was Founder/CEO of Genyx Medical, Inc., which he sold to C.R. Bard in 2005. Prior to founding Genyx, he was with Micro Therapeutics, Inc. (now Medtronic Neurovascular) from 1994 through 1997 as its CFO. Prior to MTI, Tom served since 1985 as CFO in several other public and private medical device companies in Orange County. He has served on the Board of OCTANe since 2006.
